Vaxart, Inc. (VXRT)
OTCMKTS · Delayed Price · Currency is USD
0.5078
-0.0222 (-4.19%)
Jul 16, 2026, 3:54 PM EST
Vaxart Market Cap
Vaxart has a market cap or net worth of $124.23 million as of July 17, 2026. Its market cap has increased by 45.90% in one year.
Market Cap
124.23M
Enterprise Value
75.41M
Revenue
255.61M
Ranking
n/a
PE Ratio
3.26
Stock Price
$0.51
ChartMarket Cap Chart
Since February 14, 2018, Vaxart's market cap has increased from 60.35M to 124.23M, an increase of 105.85%. That is a compound annual growth rate of 8.95%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 16, 2026 | 124.23M | 49.44% |
| Dec 31, 2025 | 83.13M | -44.81% |
| Dec 31, 2024 | 150.61M | 72.95% |
| Dec 29, 2023 | 87.09M | -30.95% |
| Dec 30, 2022 | 126.12M | -83.97% |
| Dec 31, 2021 | 786.86M | 25.88% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Feb 14, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Glorywin Entertainment Group | 359.76M |
| CytoDyn | 302.13M |
| Northwest Biotherapeutics | 274.47M |
| HST Global | 99.00M |
| NDT Pharmaceuticals | 71.78M |
| BioStem Technologies | 67.36M |
| Cell Source | 54.19M |
| Nuo Therapeutics | 47.44M |